Delivery Order SPE2DB24D3014-SPE2DB26FKRVT
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,071.28 to AmerisourceBergen Drug Corp for the supply of Estrogen-Methyltestosterone tablets (100 count) on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $1,454.40 to AmerisourceBergen Drug Corp for Estrogen-Methyltestosterone tablets (100 count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,161.18 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Estrogen-Methyltestosterone tablets (100 count). This firm fixed price contract, with an ultimate completion date of August 7, 2025, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at the...
- The Defense Logistics Agency awarded a $1,940.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for estrogen-methyltestosterone tablets (100-count) on September 25, 2025, with completion scheduled for September 26, 2025. This non-set-aside contract was competitively awarded to the major pharmaceutical distributor and reflects routine medical supply procurement for military healthcare needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,317.41 to AmerisourceBergen Drug Corp for Estrogen-Methyltestosterone tablets (100-count) with a firm fixed price structure. This non-set-aside contract was awarded on August 19, 2025, with an ultimate completion date of August 20, 2025. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- This federal contract award, valued at $1,318.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ESTROGEN-METHYLTESTOS F.S. TAB 100S, a medical product, and has an ultimate completion date of June 28, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation indicated. Amerisourcebergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,257.38, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC, valued at $999,999,999, serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,182.00, is for the delivery of Estrogen-Methyltestos H.S. Tablets in 100 count bottles. This is a firm fixed-price delivery order contract with an ultimate completion date of April 4, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp also...
- This is a delivery order (contract) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ESTROGEN-METHYLTESTOS H.S. TAB 100S. The contract has a ceiling value of $1,800.18 and a completion date of July 26, 2024. It is a firm fixed-price contract, and there is no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to...
- The Defense Logistics Agency awarded a $448 delivery order to Amerisourcebergen Drug Corporation for estrogen-methyltestosterone tablets. The firm fixed price order calls for delivery of 100 count packages of the pharmaceutical product to a facility in Conshohocken, Pennsylvania by August 21, 2023. Amerisourcebergen will perform as the prime contractor, with the Defense Logistics Agency serving as the contracting agency. This delivery order was issued against an existing DLA pharmaceuticals...
- SPE2DB24D3014Indefinite Delivery Contract
- SPE2DB24D3014-SPE2DB26FKRVTDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,535.70 to AmerisourceBergen Drug Corp for Estrogen-Methyltestosterone tablets (100 count) on October 28, 2025, with completion scheduled for October 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and reflects a standard transactional delivery under the company's existing pharmaceutical supply framework with the federal government. Performance will be executed from the vendor's Conshohocken, Pennsylvania headquarters. This delivery order operates as a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's federal contract portfolio demonstrates its capability as a major pharmaceutical distributor serving critical federal medical procurement needs through open competition, delivering everything from specialty medications and vaccines to medical devices across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/28/25 |